Clinical trial
Absorption, Distribution, Metabolism And Excretion Study For GSK221149A
NCT00457925 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00457925 |
|---|---|
| Title | Absorption, Distribution, Metabolism And Excretion Study For GSK221149A |
| Official title | An Open-label, Two Period Study to Determine the Excretion Balance and Pharmacokinetics of [14C]-GSK221149A, Administered as Single Doses of an Oral Solution and an Intravenous Infusion to Healthy Female Volunteers |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Obstetric Labour, Premature, Premature Labor |
| Intervention type | Drug |
| Interventions | GSK221149A |
| Enrollment | 6 |
| Start date | Oct 1, 2006 |
| First posted | Apr 9, 2007 |
| Last update posted | Mar 19, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: